Previous studies have shown that PALS-22 inhibits the IPR transcriptional program, which includes a suite of pals genes as well as the cullin-RING ubiquitin ligase components, promoting proteostasis capacities and resistance to infection with intracellular pathogens, such as N. parisii. This evidence concerns the gene CTSC and infection.